Full-stack contract research and manufacturing capabilities validated across chromatographic fingerprints and verified efficacy trials.
How stringent cross-border compliance, clean beauty genomics, and analytical chemistry are redefining OEM/ODM supplier benchmarks.
The global cosmeceutical and clean-label cosmetic market has entered an era of clinical transparency. Gone are the days when simple botanical extracts with arbitrary concentrations could justify premium market placement. Under stringent oversight such as the European Union's Regulation (EC) No 1223/2009, the United States MoCRA (Modernization of Cosmetics Regulation Act of 2022), and China's CSAR (Cosmetics Supervision and Administration Regulation), enterprise procurement requires demonstrable biochemical safety dossiers, proven mechanism of action (MoA), and batch-level standardization.
MedGence (Yineng Pharma) stands at the nexus of classical phytochemistry and contemporary contract development and manufacturing. By mobilizing over 14 years of research infrastructure that has modernized 83 classic Traditional Chinese Medicine (TCM) formulations and registered 56 hospital preparations, we supply Tier-1 personal care brands with verifiable plant actives. Our high-performance thin-layer chromatography (HPTLC), HPLC, and GC chromatographic fingerprinting ensure that every commercial cosmetic batch retains therapeutic molecular consistency.
Supercritical CO2 fluid extraction, subcritical water extraction, and multi-stage enzymatic biotransformation enhance active molecule concentration (e.g., ginsenosides, madecassoside) while eliminating harmful solvent residues.
Learn about Extraction R&D →Cosmetic regulators demand that multi-component botanical derivatives possess reproducible chromatography. MedGence institutes proprietary chemical fingerprints guaranteeing identical peak ratios across four seasons.
Explore Analytical Protocols →Efficacy claims regarding anti-wrinkle, skin barrier repair, brightening, and anti-photoaging require certified in vitro cellular assays and double-blind, randomized human trials before global retail distribution.
Discover Clinical Study Services →Addressing the core bottlenecks multinational beauty brands face when sourcing botanical cosmetic actives and turnkey formulations.
The Bottleneck: Climatic variances and fluctuating soil conditions cause significant disparities in secondary metabolites from raw herbs.
Our Macro Solution: Systematic potency evaluation cross-referencing multi-regional geographic origins and harvest windows, accompanied by HPLC tracking.
The Bottleneck: Cosmetic Safety Assessment Reports now necessitate exhaustive toxicological profiles, skin sensitization assays, and heavy metal assays.
Our Macro Solution: End-to-end toxicological packages including LD50 acute/chronic tests, Ames genotoxicity tests, and cellular trans-epithelial studies.
The Bottleneck: Lab formulations often destabilize or suffer chemical degradation when scaled from 5-liter glass reactors to 5,000-liter industrial tanks.
Our Macro Solution: Seamless CDMO pilot transfer protocols, fine-tuning agitation dynamics, thermal curves, vacuum concentration, and microencapsulation.
The Bottleneck: High risk of unique proprietary cosmeceutical blend leakage in non-pharmaceutical manufacturing hubs.
Our Macro Solution: Closed-loop entrusted contract structure backed by legally binding non-disclosure, isolated pilot bays, and dedicated proprietary tooling.
Quantifiable R&D achievements engineered alongside China's Tier-1 pharmaceutical institutions, academic research centers, and global skincare consortiums.
A closed-loop infrastructure allowing cosmetic brands to transition seamlessly from compound identification to certified commercial batches.
Systematically identify active phytochemical compounds (alkaloids, polyphenols, saponins, triterpenes) with targeted dermatological efficacy. Leveraging our multi-decade database, we isolate high-density botanical sources to balance efficacy, raw-material cost, and bio-sustainability.
View screening protocols →Botanical potency varies drastically depending on altitude, soil chemistry, sunshine hours, and harvest cycles. We evaluate harvest windows and regional origins (Geo-authentic / Dao-Di herbs) to establish high-potency procurement specs that prevent manufacturing discrepancies.
Explore sourcing science →Validation of comprehensive qualitative and quantitative testing regimes utilizing HPTLC, HPLC-MS/MS, GC-FID, and UV-Vis spectrophotometry. We deliver certified reference standards, peak retention curves, and limits of detection (LOD/LOQ) for cosmetic batch release.
Inspect chromatography methods →Industrial optimization of raw biomass pretreatment, temperature-controlled solvent extraction, resin column chromatography, membrane filtration, and spray drying. We establish the critical process parameters (CPPs) ensuring maximum active yield and solvent recovery.
Process optimization details →Transforming delicate herbal fractions into shelf-stable cosmetic emulsions, serums, hydrogels, and creams without phase separation or oxidation. Our rheologists and physical chemists ensure superior dermal absorption, skin feel, and active ingredient stability over 36 months.
Explore formulation services →Satisfy MoCRA and international cosmetic safety dossiers through exhaustive toxicology testing: Median Lethal Dose (LD50), repeated-dose 28/90-day dermal toxicity, bacterial reverse mutation (Ames test), in vitro mammalian chromosomal aberration, and ocular irritation models.
Toxicological safety scopes →Rapid, high-fidelity cellular screening on human keratinocytes (HaCaT), dermal fibroblasts (HDF), and melanoma cell lines. Validating tyrosinase inhibition (whitening), elastase & collagenase downregulation (anti-aging), and ROS scavenging antioxidant capacity.
View in vitro assay library →Robust preclinical evaluation in controlled dermatological animal models to verify barrier recovery, trans-epidermal water loss (TEWL) reduction, atopic skin mitigation, and wound regeneration kinetics, establishing unambiguous scientific credibility before clinical pilot phases.
Review animal testing protocols →Full GCP-compliant clinical evaluation for cosmeceuticals and therapeutic botanicals. Conducting patch tests for hypoallergenic claims, 4-to-12 week double-blind efficacy trials with VISIA-CR skin imaging, corneometer moisture tracking, and cutaneous elasticity analysis.
Clinical trial documentation →Deep Traditional Medicine formula harmonization. We optimize herbal pairings where secondary compounds enhance bioavailability, reduce cellular cytotoxicity, and trigger multi-pathway biological responses, providing brands with proprietary, patentable active combinations.
Synergy formulation catalog →Pilot to metric-ton commercial supply of active botanical compounds: standardized concentrated botanical distillates, freeze-dried active powders, liposomal active dispersions, and pure aromatic essential oils, protected under strict pharmaceutical cleanroom standards.
Request active ingredient specs →Complete ODM contract manufacturing for finished cosmeceuticals, functional oral beauty liquids, skin-firming softgels, effervescent botanical drink crystals, and topical preparations. Direct oversight from pharmaceutical specialists guarantees strict regulatory conformity.
Request turnkey CDMO pricing →Providing regulatory certainty for export markets across North America, the European Union, Southeast Asia, and China.
Full support for cosmetic product facility registration, cosmetic safety substantiation documentation, adverse event reporting workflows, and fragrance allergen labeling in strict conformity with Modernization of Cosmetics Regulation Act criteria.
Preparation of comprehensive Product Information Files (PIF), Cosmetic Product Safety Reports (CPSR Part A & B) certified by qualified European toxicologists, ensuring straightforward CPNP (Cosmetic Products Notification Portal) submission.
Navigating China's rigorous National Medical Products Administration regulations. Provision of safety data sheets, raw material submission codes (NMPA Annex 14), toxicological data, and customized localized efficacy substantiation testing.
Strategic technological initiatives driving our next-generation cosmetic contract manufacturing infrastructure.
Deploying machine-learning molecular modeling to predict phytocompound interaction with dermal receptors, reducing initial compound screening cycles from months to days.
Scaling up liposomal and biomimetic lipid nanoparticle carrier platforms to enhance the transdermal delivery rate of labile polyphenols and hydrophilic plant polysaccharides by over 400%.
Establishing cell factory fermentation lines to produce rare active phytomolecules without depleting wild biological resources, assuring absolute purity and zero botanical cytotoxicity.
Formulating dynamic postbiotic and prebiotic botanical complexes engineered to preserve cutaneous acid-mantle diversity while treating inflammatory skin conditions.
Our collaborative R&D network integrates renowned national pharmaceutical groups and specialized university healthcare hospitals.
Tongrentang Group
CR Sanjiu
Sunflower Pharma
Livzon Pharma
Dihon Pharmaceutical
Golden Throat
Yangtzi River Pharma
Gofar Chuanshan
Humanwell Healthcare
SCIMYTH Group
Hanfang Pharma
Luoxin Pharma
Zhongsheng Pharma
Brilliance & Abundance
Apeloa Pharma
Heng Chang Pharma
Baotou TCM
Kamp Medicine
Santo Pharma
Kangshou Pharma
Juwang Industry
Beijing Tcmages
Ruihe Pharma
Jinchan Pharma
Kangmei Pharma
Tianjicaotang
Kingstone Unite
Shuguang Hospital
Hunan Direct TCM
1st Affiliated Hospital
2nd Xiangya Hospital
2nd Affiliated Hospital
Zhuzhou Orthopedics
Expert answers addressing qualification protocols, pilot scale-up timelines, analytics, and IP protection.
Order validated assays, preclinical toxicity dossiers, and pilot batches directly through our scientific project desk.
Partner with a proven botanical CRO/CDMO. Whether you require chromatographic active verification, GLP toxicity screening, or certified commercial batch supply, our senior scientists are ready to engineer your formulation.
